FDA.reportPublic FDA data

24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto]

RxCUI
1796096
RxNorm name
24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto]
Display name
24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto]
Full name
24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Jentadueto XRLINAGLIPTIN AND METFORMIN HYDROCHLORIDEBoehringer Ingelheim Pharmaceuticals, Inc.3d02a4d4-d312-80b4-05c4-691b8f0aa7aa2026-08-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1796096

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3d02a4d4-d312-80b4-05c4-691b8f0aa7aaJentadueto XR 5 MG / 1000 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Jentadueto] [SBD] · Jentadueto XR (linagliptin 5 MG / metformin HCl 1000 MG) 24HR Extended Release Oral Tablet [SY]39These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 201220240524